Quality improvement guidelines for transjugular intrahepatic portosystemic shunts

Journal of Vascular and Interventional Radiology

Volumn 12, Issue 2, 2001, Pages 131-136

  Haskal, Z J ^a   Martin, L ^a   Cardella, J F ^a   Cole, P E ^a   Drooz, A ^a   Grassi, C J ^a   McCowan, T C ^a   Meranze, S G ^a   Neithamer, C D ^a   Oglevie, S B ^a   Roberts, A C ^a   Sacks, D ^a   Silverstein, M I ^a   Swan, T L ^a   Towbin, R B ^a   Lewis, C A ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

Portosystemic; Shunts; Standards of practice

Indexed keywords

ASCITES; ESOPHAGUS VARICES BLEEDING; HUMAN; HYDROTHORAX; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; TREATMENT OUTCOME;

EID: 0035113878     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(07)61817-X     Document Type: Article

References (74)

1. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: A randomized, controlled trial
2. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices
3. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial: Gruppo Italiano Studio TIPS (G.I.S.T.)
4. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: A randomized, controlled trial
5. Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: A randomized trial
6. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage
7. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites
8. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites
9. Renal sodium retention in liver disease
10. Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites
11. Severe ascites: Efficacy of the transjugular intrahepatic portosystemic shunt in treatment
12. Refractory ascites: Early experience in treatment with transjugular intrahepatic portosystemic shunt
13. Transjugular intrahepatic portosystemic shunts: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial
14. Refractory ascites: Midterm results of treatment with a transjugular intrahepatic portosystemic shunt
15. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites
16. Transjugular intrahepatic portosystemic shunts for refractory ascites: Assessment of clinical and hormonal response and renal function
17. Transjugular intrahepatic portosystemic shunt for refractory ascites: Shunt diameter-optimizing risks and benefits
18. Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: Effect on body weight and Child-Pugh score
19. Dysfunction of a TIPS (transjugular intrahepatic portosystemic shunt) and chylous ascites
20. Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt
21. Resolution of hepatic hydrothorax after transjugular intrahepatic portosystemic shunt (TIPS) placement
22. Intestinal varices: Treatment with the transjugular intrahepatic portosystemic shunt
23. The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy
24. Treatment of Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt
25. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome
26. Budd-Chiari syndrome: Technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt
27. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: Review of indications and problems
28. 2-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: Results in 90 patients
29. Creation of transjugular intrahepatic portosystemic shunt (TIPS) with the Wallstent endoprosthesis: Results in 100 patients 1993
30. Reporting standards for transjugular intrahepatic portosystemic shunts. Technology Assessment Committee of the SCVIR
31. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding
32. Immediate endoscopic diagnosis of upper gastrointestinal bleeding: Its accuracy and value in relation to associated pathology
33. Emergency endoscopy after gastrointestinal haemorrhage in 50 patients with portal hypertension
34. Complications of transjugular intrahepatic portosystemic shunt: A comprehensive review
35. Vascular complication of a transjugular intrahepatic portacaval stent
36. Review article: Update on the role of transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of complications of portal hypertension
37. The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Diseases Advisory Board
38. Hepatic infarction: Unusual complication of a transjugular intrahepatic portosystemic shunt
39. Cardiac perforation due to Wallstent embolization: A fatal complication of the transjugular intrahepatic portosystemic shunt procedure
40. Arteriobiliary fistula after transjugular intrahepatic portosystemic shunt: A life-threatening complication of the new technique for therapy of portal hypertension
41. Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone
42. Acute and chronic complications after implantation of a transjugular intrahepatic portosystemic shunt-a prospective study in 53 patients
43. Endocarditis as a complication of a transjugular intrahepatic portosystemic stent-shunt
44. Hepatic arterial injury after transjugular intrahepatic portosystemic shunt placement: Report of two cases
45. Transjugular intrahepatic portosystemic shunt-related arterial injuries: Prospective comparison of large- and small-gauge needle systems
46. Prognostic factors predicting early demise in patients undergoing transjugular intrahepatic portosystemic shunt placement
47. Creation of a stenotic stent to reduce transjugular intrahepatic portosystemic shunt flow
48. Impact of transjugular intrahepatic portosystemic shunts on liver-transplantation: A controlled analysis
49. Hemodynamic consequences of therapeutic portosystemic shunting: Recent experience with transjugular intrahepatic portosystemic shunts
50. Hepatic infarction complicating a transjugular intrahepatic portosystemic shunt
51. Shunt occlusion and acute portal, splenic, and mesenteric venous thrombosis complicating placement of a transjugular intrahepatic portosystemic shunt
52. Duplex and color Doppler sonography of complications after percutaneous interventional vascular procedures
53. Transjugular intrahepatic portosystemic shunt (TIPS) complicated by complete heart block
54. Inadvertent catheterization of the hepatic artery during placement of transjugular intrahepatic portosystemic shunts
55. Transjugular intrahepatic portosystemic shunts: Current status
56. Successful reversal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic portosystemic shunts
57. Radiodermatitis after transjugular intrahepatic portosystemic shunt
58. Beware of TIPS in liver transplant candidates. Transjugular intrahepatic portosystemic shunt
59. A study of patient radiation doses in interventional radiological procedures
60. Fatal hemodynamic consequences of therapeutic closure of a transjugular intrahepatic portosystemic shunt
61. Wallstent misplaced during transjugular placement of an intrahepatic portosystemic shunt: Retrieval with a loop snare
62. The hematologic consequences of transjugular intrahepatic portosystemic shunts
63. Vegetative infection of transjugular intrahepatic portosystemic shunts
64. Arterioportal fistula after transjugular intrahepatic portosystemic shunt placement
65. Hepatic laceration from wedged venography performed before transjugular intrahepatic portosystemic shunt placement
66. Extrahepatic portal vein puncture and intra-abdominal hemorrhage during transjugular intrahepatic portosystemic shunt creation
67. A fistula from the portal vein to the bile duct: An unusual complication of transjugular intrahepatic portosystemic shunt
68. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: Results of a prospective controlled study
69. Encephalopathy after transjugular intrahepatic portosystemic shunting: Analysis of incidence and potential risk factors
70. Hepatic-encephalopathy after transjugular intrahepatic portosystemic shunts: Incidence and risk-factors
71. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: Clinical, laboratory, psychometric, and electroencephalographic investigations
72. Consensus methods: Characteristics and guidelines for use
73. The appropriateness of use of coronary artery bypass graft surgery in New York State
74. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites